Prime Medicine (PRME) Assets Average (2022 - 2026)

Prime Medicine (PRME) has 5 years of Assets Average data on file, last reported at $318.7 million in Q1 2026.

• Quarterly Assets Average rose 1.88% year-over-year to $318.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $318.7 million (up 1.88% YoY) and the FY2025 annual result came in at $320.1 million, up 30.3% from the prior year.
• Assets Average eased to $318.7 million in Q1 2026, from $363.9 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $363.9 million in Q4 2025 to a low of $216.5 million in Q4 2023.
• A 5-year average of $298.7 million and a median of $301.2 million in 2023 frame the typical range for Assets Average.
• The widest YoY moves for Assets Average: up 45.57% in 2024, down 25.4% in 2024.
• Tracing PRME's Assets Average over 5 years: stood at $287.8 million in 2022, then slipped by 24.77% to $216.5 million in 2023, then soared by 45.57% to $315.1 million in 2024, then grew by 15.46% to $363.9 million in 2025, then retreated by 12.41% to $318.7 million in 2026.
• The last three Assets Average figures came in at $318.7 million (Q1 2026), $363.9 million (Q4 2025), and $332.0 million (Q3 2025), per Business Quant data.